– Increase in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech ingredients market
PORTLAND, Ore., July 5, 2021 /PRNewswire/ — Allied Market Research published a report, titled, «Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, and Blood Factors), and Expression Systems (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, and Insect Expression Systems): Global Opportunity Analysis and Industry Forecast, 2021–2028.» According to the report, the global biotech ingredients industry was estimated at $51.3 billion in 2020, and is expected to hit $75.3 billion by 2028, registering a CAGR of 4.8% from 2021 to 2028.
Drivers, restraints, and opportunities-
Increase in consumer preference from synthetic to bio-based ingredients and development in biotechnology propel the growth of the global biotech ingredients market. On the other hand, limited availability of raw materials impedes the growth to some extent. Nevertheless, favorable government policies and technological advancements in bio-engineering are anticipated to pave the way for lucrative opportunities in the future.
Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/11710
- The outbreak of COVID-19 led to either closure or suspension of production activities in most industrial units across the world, thereby hampering the global biotech ingredients market.
- However, government bodies in different countries have come up with relaxed dictums, which is expected to ameliorate the global situation and market is projected to recoup soon.
The Active Pharmaceutical Ingredients (APIs) segment to retain its dominance by 2028-
Based on type, the Active Pharmaceutical Ingredients (APIs) segment accounted for nearly three-fifths of the total market share in 2020 and is expected to rule the roost by the end of 2028, due to increased use of generic medicines, especially herbal immunity boosters, in the wake of pandemic. The biosimilars segment, on the other hand, would exhibit the fastest CAGR of 5.0% during the forecast period. This is attributed to the fact that they are used abundantly as both finished as well as raw materials for many generic and specific medicines.
Get Detailed COVID-19 Impact Analysis on the Biotech Ingredients Market @ https://www.alliedmarketresearch.com/request-for-customization/11710?reqfor=covid
The monoclonal antibodies segment to rule the roost-
Based on product, the monoclonal antibodies segment contributed to more than one-fifth of the total market revenue in 2020 and is expected to dominate by 2028, due to growing demand for organic and herbal medicines for various diseases. However, the hormones and growth factors segment would cite the fastest CAGR of 5.5% during from 2021 to 2028, owing to increasing health and hormonal problems that arise from the contemporary lifestyle.
Europe, followed by Asia-Pacific and North America, had the major share in 2020-
Based on region, Europe held the major share in 2020, garnering nearly two-fifths of the global market, This is attributed to huge consumer base and favorable support from several government bodies in the province. At the same time, the market across Asia-Pacific would register the fastest CAGR of 5.2% from 2021 to 2028. The other regions studied in the report include LAMEA and North America
Frontrunners in the industry-
- Novartis International AG
- AstraZeneca plc.
- Pfizer Inc.
- Merck & Co.
- Mylan, Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
Interested in Procuring This Report? Visit Here:
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of «Market Research Reports» and «Business Intelligence Solutions.» AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: 1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on: LinkedIn Twitter